Swiss-based medical technology company MedAlliance has been acquired by Cordis in a deal that could be worth up to $1.135 billion. The deal consists of a 2022 investment of $35 million and a 2023 upfront closing payment of $200 million, together with regulatory achievement milestones of up to $125 million and commercial milestones of up […]
